Theralase Technologies Inc. TLTFF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -767.40K | -752.10K | -491.80K | -734.70K | -688.10K |
| Total Depreciation and Amortization | 36.80K | 43.20K | 52.20K | 48.10K | 44.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.40K | 82.30K | 42.30K | 124.10K | 122.70K |
| Change in Net Operating Assets | -204.50K | 448.40K | -483.50K | 63.70K | -214.80K |
| Cash from Operations | -888.80K | -178.30K | -880.90K | -498.90K | -735.70K |
| Capital Expenditure | -3.30K | -700.00 | 30.20K | -11.00K | -8.10K |
| Sale of Property, Plant, and Equipment | 1.20K | 1.50K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.10K | 800.00 | 30.20K | -11.00K | -8.10K |
| Total Debt Issued | -- | -- | 275.00K | 100.00K | -- |
| Total Debt Repaid | -33.20K | -26.50K | -12.40K | -29.30K | -34.30K |
| Issuance of Common Stock | 5.52M | 1.09M | 1.03M | 668.20K | 977.90K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -2.00K | -- |
| Cash from Financing | 3.97M | 776.00K | 923.80K | 535.00K | 682.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 0.00 |
| Net Change in Cash | 3.08M | 598.50K | 73.10K | 25.20K | -61.80K |